Sofinnova Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-176,181	Closed	-$47.6M	–	66
2025 Q1	$47.6M	Buy	176,181 +66,024	+60%	+$17M	3.59%	8
2024 Q4	$25.9M	Buy	+110,157	New	+$29M	1.9%	17
2024 Q3	–	Sell	-147,929	Closed	-$35.9M	–	65
2024 Q2	$35.9M	Buy	147,929 +44,893	+44%	+$7.09M	2.27%	18
2024 Q1	$15.4M	Buy	+103,036	New	+$17.2M	0.91%	31
2023 Q2	–	Sell	-448	Closed	-$89.7K	–	53
2023 Q1	$89.7K	Sell	448 -56,000	-99%	-$11.8M	0.01%	52
2022 Q4	$13.4M	Buy	+56,448	New	+$12M	0.82%	28
2020 Q3	–	Hold	0	–	–	–	71
2020 Q2	–	Hold	0	–	–	–	80
2020 Q1	–	Hold	0	–	–	–	65
2019 Q4	–	Hold	0	–	–	–	62
2019 Q3	–	Sell	-27,792	Closed	-$2.02M	–	75
2019 Q2	$2.02M	Sell	27,792 -78,824	-74%	-$6.05M	0.19%	58
2019 Q1	$9.96M	Buy	+106,616	New	+$8.92M	1.02%	21